Cargando…

A retrospective study on Xpert MTB/RIF for detection of tuberculosis in a teaching hospital in China

BACKGROUND: The Xpert MTB/RIF assay is an automated molecular test that is designed to simultaneously detect Mycobacterium tuberculosis (MTB) complex and rifampin resistance. However, there are relatively few studies on this method in China. Xpert has been routinely used at Peking University People’...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shuguang, Lin, Liyan, Zhang, Feifei, Zhao, Chunjiang, Meng, Han, Wang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245878/
https://www.ncbi.nlm.nih.gov/pubmed/32448123
http://dx.doi.org/10.1186/s12879-020-05004-8
_version_ 1783537837083197440
author Li, Shuguang
Lin, Liyan
Zhang, Feifei
Zhao, Chunjiang
Meng, Han
Wang, Hui
author_facet Li, Shuguang
Lin, Liyan
Zhang, Feifei
Zhao, Chunjiang
Meng, Han
Wang, Hui
author_sort Li, Shuguang
collection PubMed
description BACKGROUND: The Xpert MTB/RIF assay is an automated molecular test that is designed to simultaneously detect Mycobacterium tuberculosis (MTB) complex and rifampin resistance. However, there are relatively few studies on this method in China. Xpert has been routinely used at Peking University People’s Hospital (PKUPH) since November 2016. Thus, the aim of this study was to evaluate the performance of Xpert, and provide a reference and guidance for the detection and diagnosis of TB in non-TB specialized hospitals. METHODS: The medical records of inpatients simultaneously tested with Xpert, acid-fast bacilli (AFB) smear microscopy, and interferon-gamma release assay (IGRA, by T-SPOT®.TB) at PKUPH from November 2016 to October 2018 were reviewed. Active TB cases were considered according to a composite reference standard (CRS). Then, the three methods were evaluated and compared. RESULTS: In total, 787 patients simultaneously tested with Xpert, AFB, and IGRA were enrolled; among them 11.3% (89/787) were diagnosed and confirmed active pulmonary TB (PTB, 52 cases), extrapulmonary TB (EPTB, 17 cases), and tuberculous pleurisy (TP, 20 cases). The sensitivity of Xpert in detecting PTB, EPTB, and TP was 88.5, 76.5, and 15.0%, respectively, which was slightly lower than IGRA (96.2, 82.4, and 95.0%, respectively), but higher than AFB (36.5, 11.8, and 0%, respectively); IGRA showed the highest sensitivity, but its specificity (55.9, 67.1, and 45.2%, respectively) was significantly lower than Xpert (99.6, 99.4, and 100%, respectively) and AFB (99.0, 99.4, and 100%, respectively) (P < 0.001). The sensitivity of Xpert in detecting lung tissue, cerebrospinal fluid, lymph nodes, and joint fluid was 100%, followed by sputum (88.5%), alveolar lavage (85.7%), and bronchoscopy secretion (81.2%); the pleural fluid sensitivity was the lowest, only 15.0%. For AFB negative patients, the sensitivity of Xpert in detecting PTB, EPTB, and TP was 84.9, 73.3, and 15.0%, respectively. CONCLUSIONS: Xpert showed both high sensitivity and high specificity, and suggested its high value in TB diagnosis; however, the application of pleural fluid is still limited, and should be improved. Owing to the high sensitivity of IGRA, it is recommended for use as a supplementary test, especially for assisting in the diagnosis of TP and EPTB.
format Online
Article
Text
id pubmed-7245878
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72458782020-06-01 A retrospective study on Xpert MTB/RIF for detection of tuberculosis in a teaching hospital in China Li, Shuguang Lin, Liyan Zhang, Feifei Zhao, Chunjiang Meng, Han Wang, Hui BMC Infect Dis Research Article BACKGROUND: The Xpert MTB/RIF assay is an automated molecular test that is designed to simultaneously detect Mycobacterium tuberculosis (MTB) complex and rifampin resistance. However, there are relatively few studies on this method in China. Xpert has been routinely used at Peking University People’s Hospital (PKUPH) since November 2016. Thus, the aim of this study was to evaluate the performance of Xpert, and provide a reference and guidance for the detection and diagnosis of TB in non-TB specialized hospitals. METHODS: The medical records of inpatients simultaneously tested with Xpert, acid-fast bacilli (AFB) smear microscopy, and interferon-gamma release assay (IGRA, by T-SPOT®.TB) at PKUPH from November 2016 to October 2018 were reviewed. Active TB cases were considered according to a composite reference standard (CRS). Then, the three methods were evaluated and compared. RESULTS: In total, 787 patients simultaneously tested with Xpert, AFB, and IGRA were enrolled; among them 11.3% (89/787) were diagnosed and confirmed active pulmonary TB (PTB, 52 cases), extrapulmonary TB (EPTB, 17 cases), and tuberculous pleurisy (TP, 20 cases). The sensitivity of Xpert in detecting PTB, EPTB, and TP was 88.5, 76.5, and 15.0%, respectively, which was slightly lower than IGRA (96.2, 82.4, and 95.0%, respectively), but higher than AFB (36.5, 11.8, and 0%, respectively); IGRA showed the highest sensitivity, but its specificity (55.9, 67.1, and 45.2%, respectively) was significantly lower than Xpert (99.6, 99.4, and 100%, respectively) and AFB (99.0, 99.4, and 100%, respectively) (P < 0.001). The sensitivity of Xpert in detecting lung tissue, cerebrospinal fluid, lymph nodes, and joint fluid was 100%, followed by sputum (88.5%), alveolar lavage (85.7%), and bronchoscopy secretion (81.2%); the pleural fluid sensitivity was the lowest, only 15.0%. For AFB negative patients, the sensitivity of Xpert in detecting PTB, EPTB, and TP was 84.9, 73.3, and 15.0%, respectively. CONCLUSIONS: Xpert showed both high sensitivity and high specificity, and suggested its high value in TB diagnosis; however, the application of pleural fluid is still limited, and should be improved. Owing to the high sensitivity of IGRA, it is recommended for use as a supplementary test, especially for assisting in the diagnosis of TP and EPTB. BioMed Central 2020-05-24 /pmc/articles/PMC7245878/ /pubmed/32448123 http://dx.doi.org/10.1186/s12879-020-05004-8 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Li, Shuguang
Lin, Liyan
Zhang, Feifei
Zhao, Chunjiang
Meng, Han
Wang, Hui
A retrospective study on Xpert MTB/RIF for detection of tuberculosis in a teaching hospital in China
title A retrospective study on Xpert MTB/RIF for detection of tuberculosis in a teaching hospital in China
title_full A retrospective study on Xpert MTB/RIF for detection of tuberculosis in a teaching hospital in China
title_fullStr A retrospective study on Xpert MTB/RIF for detection of tuberculosis in a teaching hospital in China
title_full_unstemmed A retrospective study on Xpert MTB/RIF for detection of tuberculosis in a teaching hospital in China
title_short A retrospective study on Xpert MTB/RIF for detection of tuberculosis in a teaching hospital in China
title_sort retrospective study on xpert mtb/rif for detection of tuberculosis in a teaching hospital in china
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245878/
https://www.ncbi.nlm.nih.gov/pubmed/32448123
http://dx.doi.org/10.1186/s12879-020-05004-8
work_keys_str_mv AT lishuguang aretrospectivestudyonxpertmtbriffordetectionoftuberculosisinateachinghospitalinchina
AT linliyan aretrospectivestudyonxpertmtbriffordetectionoftuberculosisinateachinghospitalinchina
AT zhangfeifei aretrospectivestudyonxpertmtbriffordetectionoftuberculosisinateachinghospitalinchina
AT zhaochunjiang aretrospectivestudyonxpertmtbriffordetectionoftuberculosisinateachinghospitalinchina
AT menghan aretrospectivestudyonxpertmtbriffordetectionoftuberculosisinateachinghospitalinchina
AT wanghui aretrospectivestudyonxpertmtbriffordetectionoftuberculosisinateachinghospitalinchina
AT lishuguang retrospectivestudyonxpertmtbriffordetectionoftuberculosisinateachinghospitalinchina
AT linliyan retrospectivestudyonxpertmtbriffordetectionoftuberculosisinateachinghospitalinchina
AT zhangfeifei retrospectivestudyonxpertmtbriffordetectionoftuberculosisinateachinghospitalinchina
AT zhaochunjiang retrospectivestudyonxpertmtbriffordetectionoftuberculosisinateachinghospitalinchina
AT menghan retrospectivestudyonxpertmtbriffordetectionoftuberculosisinateachinghospitalinchina
AT wanghui retrospectivestudyonxpertmtbriffordetectionoftuberculosisinateachinghospitalinchina